Skip to content

Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

A Single Center, Translational Study on the Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Patients Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07561567
Acronym
E20241186
Enrollment
50
Registered
2026-05-01
Start date
2026-05-10
Completion date
2026-12-31
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Non-Small Cell

Keywords

Respiratory Movement Management

Brief summary

The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is: Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors? Participants will: Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement

Interventions

DEVICEChest and abdominal compression

Abdominal compression suppresses respiratory movement in patients

DEVICEbreathing management

Apply pressure to the patient's abdomen to achieve respiratory movement inhibition

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Clinical diagnosis is solitary peripheral lung cancer, and after comprehensive evaluation by the participating physicians based on the patient's clinical data, it is suitable for receiving SBRT treatment;

Exclusion criteria

Central or super central lung cancer patients who are intolerant or unwilling to undergo respiratory suppression and chest and abdominal compression fixation

Design outcomes

Primary

MeasureTime frameDescription
Tumor displacement rangeWithin 6 months after enrollmentBased on 4DCT for delineating tumor motion range and extracting radiomics features in patients with and without respiratory management

Countries

China

Contacts

CONTACTXuyao Yu Dr
yuxuyao@tmu.edu.cn86-022-23341405

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026